Tears for Life was created in September 2008 as a collaboration between researchers at the University of Arkansas for Medical Sciences and MBA students at the University of Arkansas' Walton College of Business.  We have an exclusive license for a patent-pending technology from UAMS to develop an innovative, non-invasive, and convenient screening tool that can detect breast cancer using proteins found in women's tears.



These protein patterns create a multiple marker "barcode" that accurately identifies the presence of breast cancer in the body.  Our vision is that the test will make breast cancer screening easier and more accessible for women, resulting in higher screening rates, earlier diagnosis and treatment, increased survival rates, and reduced treatment costs for patients and insurers.